Skip to main content
Top
Published in: Diabetologia 3/2004

01-03-2004 | Observation

Acute metabolic cataract as a first manifestation of diabetes mellitus in a 12-year-old girl

Authors: Y. Suzuki, MD, K. Nishimaki, M. Taniyama, T. Muramatsu, Y. Atsumi, K. Matsuoka, S. Ohta

Published in: Diabetologia | Issue 3/2004

Login to get access

Excerpt

To the Editor: We report a case of juvenile cataract and Type 2 diabetes in a 26-year-old female (154 cm, 51 kg). A sibling of her mother had impaired glucose tolerance. Polydipsia and leg paresthesia were apparent in this patient with cataract since the age of 10, and she was diagnosed with diabetes at the age of 12. On her first visit, her intelligence and physical examination results were normal, except for bilateral cataracts (an unusual manifestation in a 12-year-old girl). Ptosis, ophthalmoplegia and hearing loss were not observed. Her fasting plasma glucose concentration was 25.3 mmol/l, and her HbA1c was 20.1%. Other laboratory examination data were normal. She began intensive insulin treatment and 4 months later her HbA1c rapidly decreased to 5.9%, and the leg paresthesia disappeared. She underwent successful bilateral cataract extraction with intraocular lens implantation. Four years later, she stopped insulin therapy and has been under excellent control (HbA1c 6.0%) with oral hypoglycaemic agents, and she has been free of symptoms. …
Literature
1.
go back to reference Nomiyama T, Tanaka Y, Hattori N et al. (2002) Accumulation of somatic mutation in mitochondrial DNA extracted from peripheral blood cells in diabetic patients. Diabetologia 45:1577–1583CrossRefPubMed Nomiyama T, Tanaka Y, Hattori N et al. (2002) Accumulation of somatic mutation in mitochondrial DNA extracted from peripheral blood cells in diabetic patients. Diabetologia 45:1577–1583CrossRefPubMed
2.
3.
go back to reference Isashiki Y, Nakagawa M, Ohba N et al. (1998) Retinal manifestations in mitochondrial diseases associated with mitochondrial DNA mutation. Acta Ophthalmol Scand 76:6–13CrossRefPubMed Isashiki Y, Nakagawa M, Ohba N et al. (1998) Retinal manifestations in mitochondrial diseases associated with mitochondrial DNA mutation. Acta Ophthalmol Scand 76:6–13CrossRefPubMed
4.
go back to reference Terauchi A, Tamagawa K, Morimatsu Y et al. (1996) An autopsy case of mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) with a point mutation of mitochondrial DNA. Brain Dev 18:224–229CrossRefPubMed Terauchi A, Tamagawa K, Morimatsu Y et al. (1996) An autopsy case of mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) with a point mutation of mitochondrial DNA. Brain Dev 18:224–229CrossRefPubMed
5.
go back to reference Yasukawa T, Suzuki T, Ishii N et al. (2001) Wobble modification defect in tRNA disturbs codon-anticodon interaction in a mitochondrial disease. EMBO J 20:4794–4802CrossRefPubMedPubMedCentral Yasukawa T, Suzuki T, Ishii N et al. (2001) Wobble modification defect in tRNA disturbs codon-anticodon interaction in a mitochondrial disease. EMBO J 20:4794–4802CrossRefPubMedPubMedCentral
Metadata
Title
Acute metabolic cataract as a first manifestation of diabetes mellitus in a 12-year-old girl
Authors
Y. Suzuki, MD
K. Nishimaki
M. Taniyama
T. Muramatsu
Y. Atsumi
K. Matsuoka
S. Ohta
Publication date
01-03-2004
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 3/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1333-7

Other articles of this Issue 3/2004

Diabetologia 3/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.